Medea Botanicals

Tibetan chiretta / zang yin chen

Swertia mussotii

Tibetan

Safety information

Safety information

Toxicity: Low-uncertain at traditional doses; bitter. Not fully characterised.

Contraindications: Pregnancy data insufficient; caution in biliary obstruction; gastric hyperacidity (bitter).

Interactions: Not well documented; theoretical interaction with hepatically-cleared drugs.

Pregnancy & breastfeeding: Pregnancy data insufficient.

Evidence level

Preclinical

Supported by laboratory or animal studies; not yet confirmed in humans.

Preparations

powder · whole herb

Part used: whole herb

Evidence:Preclinical
pill · whole herb

Part used: whole herb

Evidence:Preclinical
decoction · whole herb

Part used: whole herb

Traditional use: high-Plateau bile-heat/liver drug; jaundice, hepatitis, gallbladder heat; widely substituted for S. chirayita

Proposed mechanism: secoiridoid glycosides (swertiamarin, sweroside, gentiopicroside), xanthones, flavonoids — FXR activation with relief of cholestasis, oxidative-stress reduction

Evidence:Preclinical

General preparation guide →

Associated conditions

Nutritional notes

Not nutritional; bioactives are secoiridoids + xanthones.

Healing traditions

Tibetan
Sources (3)

  1. Li et al. 2018, Tibetan liver-disease review (PMID 29441019)
  2. Yun et al. 2019, Comb Chem High Throughput Screen (PMID 31692440)
  3. Dong et al. 2024, Int J Mol Sci (PMID 39408937)

All sources →

Not medical advice. Consult a qualified healthcare professional before using any plant or preparation.